Edition:
United States

VBI Vaccines Inc (VBIV.OQ)

VBIV.OQ on NASDAQ Stock Exchange Capital Market

1.92USD
21 Sep 2018
Change (% chg)

$0.07 (+3.78%)
Prev Close
$1.85
Open
$1.84
Day's High
$1.92
Day's Low
$1.84
Volume
83,567
Avg. Vol
88,804
52-wk High
$5.10
52-wk Low
$1.69

Chart for

About

VBI Vaccines Inc. is a development-stage biotechnology company. The Company's principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity.... (more)

Overall

Beta: 1.63
Market Cap(Mil.): $123.62
Shares Outstanding(Mil.): 64.38
Dividend: --
Yield (%): --

Financials

  VBIV.OQ Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -0.90 -- --
ROI: -54.13 1.50 12.72
ROE: -63.24 0.19 14.85

BRIEF-VBI Vaccines Announces Positive Final Phase 1 Study Results Of Preventative CMV Vaccine

* VBI VACCINES ANNOUNCES POSITIVE FINAL PHASE 1 STUDY RESULTS OF PREVENTATIVE CMV VACCINE

May 10 2018

BRIEF- Vaccines Posts Q1 Loss Per Share $0.19

* VBI VACCINES ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 01 2018

BRIEF-VBI Vaccines Posts Positive DSMB Review Of Recurrent Glioblastoma Study

* VBI VACCINES ANNOUNCES POSITIVE DSMB REVIEW IN PHASE 1/2A STUDY OF VBI-1901 IN RECURRENT GLIOBLASTOMA (GBM) PATIENTS

Apr 17 2018

Earnings vs. Estimates